Document Detail


Current management and future perspectives of overactive bladder (OAB) pharmacotherapy.
MedLine Citation:
PMID:  22125944     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Overactive bladder (OAB) is a condition characterized by urgency with or without urgency incontinence (UI), usually with increased daytime frequency and nocturia, which affects even 8-14% of adult population. The gold standards of OAB treatment are antimuscarinics, although this clinical entity is often poorly controlled with these agents. Thus, a progress in OAB pharmacotherapy is expected and takes place. The purpose of this article is to short review the present management of the overactive bladder with paying special attention on development of new drugs indicated for OAB treatment.
Authors:
Łukasz Dobrek; Kajetan Juszczak; Marek Wyczółkowski; Piotr Jan Thor
Related Documents :
10873244 - Chest pain management: linking tertiary and rural settings.
17670084 - Towards evidence-based medicine in cardiothoracic surgery: best bets.
21592294 - Management of the bladder in traumatic injuries of the spinal cord during the first wor...
16738044 - Copd exacerbations.5: management.
22035814 - Implementing aorn recommended practices for prevention of deep vein thrombosis.
11183424 - Marketing decision support systems for strategy building.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Acta poloniae pharmaceutica     Volume:  68     ISSN:  0001-6837     ISO Abbreviation:  Acta Pol Pharm     Publication Date:    2011 Nov-Dec
Date Detail:
Created Date:  2011-11-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  2985167R     Medline TA:  Acta Pol Pharm     Country:  Poland    
Other Details:
Languages:  eng     Pagination:  807-21     Citation Subset:  IM    
Affiliation:
Department of Pathophysiology, Jagiellonian University, Medical College Czysta 18, 31-121 Kraków, Poland. lukaszd@mp.pl
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A study on inclusion of leprosy in the curricula of pre-service health training institutions in Ugan...
Next Document:  HPLC method for identification and quantification of benzimidazole derivatives in antiparasitic drug...